Cita APA

Facchinetti, F., & Friboulet, L. (2019). Profile of entrectinib and its potential in the treatment of ROS1-positive NSCLC: Evidence to date. Lung Cancer (Auckl).

Citación estilo Chicago

Facchinetti, Francesco, y Luc Friboulet. "Profile of Entrectinib and Its Potential in the Treatment of ROS1-positive NSCLC: Evidence to Date." Lung Cancer (Auckl) 2019.

Cita MLA

Facchinetti, Francesco, y Luc Friboulet. "Profile of Entrectinib and Its Potential in the Treatment of ROS1-positive NSCLC: Evidence to Date." Lung Cancer (Auckl) 2019.